Matthew FeshbachBone Marrow-Derived vs. Adipose-Derived Stem CellsA leader in the field of stem cell therapy, Matthew Feshbach has served as chief executive officer of Ambrose Cell Therapy since founding…Jun 5, 2021Jun 5, 2021